The thiopurine S-methyltransferase gene locus – implications for clinical pharmacogenomics

Author： McLeod Howard L   Siva Chokkalingam  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.3, Iss.1, 2002-01, pp. : 89-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical Pharmacogenomics of Thiopurine S-methyltransferase

By  

Current Clinical Pharmacology, Vol. 1, Iss. 1, 2006-01 ,pp. : 119-128

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Significance of Thiopurine S-Methyltransferase Gene Polymorphisms

By  

Current Pharmacogenomics, Vol. 5, Iss. 2, 2007-06 ,pp. : 103-115

Bentham Science Publishers

Access to resources Recommend Favorite

Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond

By Karas-Kuzelicki Natasa   Mlinaric-Rascan Irena  

Pharmacogenomics, Vol. 10, Iss. 8, 2009-08 ,pp. : 1309-1322

Future Medicine

Access to resources Recommend Favorite

Do the distribution patterns of polymorphisms at the thiopurine S-methyltransferase locus in sub-Saharan populations need revision? Hints from Cabinda and Mozambique

By Oliveira E.   Quental S.   Alves S.   Amorim A.   Prata M.  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 7, 2007-07 ,pp. : 703-706

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Utility of Thiopurine S -Methyltransferase Genotyping

By Corominas H.  

American Journal of PharmacoGenomics, Vol. 4, Iss. 1, 2004-01 ,pp. : 1-8

Adis International

Access to resources Recommend Favorite